GO:0071985 multivesicular body sorting pathway: Vesicle-Mediated Protein Sorting, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071985 (multivesicular body sorting pathway) describes a vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs), leading to degradation upon MVB fusion with lysosomes or vacuoles.
• The ESCRT (Endosomal Sorting Complex Required for Transport) machinery, comprising ESCRT-0, -I, -II, -III and associated proteins such as VPS4 and ALIX, is the central molecular engine that recognizes ubiquitylated cargo and drives intraluminal vesicle formation.
• MVB sorting is essential for receptor downregulation, nutrient sensing, and cellular homeostasis; its dysfunction is linked to cancer, neurodegeneration, and developmental disorders.
• Exosome biogenesis intersects with MVB sorting, as intraluminal vesicles released into the extracellular space become exosomes, making this pathway a hotspot for cancer biomarker and therapeutic research.
• Key genes include VPS4A, VPS4B, TSG101, CHMP2A, CHMP4B, STAM1, HRS, and ALIX, many of which are studied using CRISPR knockout, point mutation, and knock-in models.
• Studying GO:0071985 requires a combination of imaging, proteomics, and CRISPR-based perturbation to dissect cargo sorting, ESCRT dynamics, and disease relevance.
Description
The multivesicular body (MVB) sorting pathway, defined by the Gene Ontology as GO:0071985, is a fundamental vesicle-mediated transport process that governs the fate of transmembrane proteins. In this pathway, cargo proteins are tagged with ubiquitin and sorted into intraluminal vesicles (ILVs) that form within the lumen of endosomes, creating multivesicular bodies. This sorting event is critical for receptor downregulation, as it ensures that activated receptors are removed from the limiting membrane and ultimately degraded when MVBs fuse with lysosomes or vacuoles. The pathway is highly conserved from yeast to humans and is executed by the endosomal sorting complex required for transport (ESCRT) machinery, a set of five complexes (ESCRT-0, -I, -II, -III, and the Vps4 complex) that sequentially recognize, concentrate, and package ubiquitylated cargo. For researchers, GO:0071985 is more than a trafficking curiosity. Defects in MVB sorting are implicated in cancer progression, where altered receptor degradation can lead to sustained proliferative signaling. Moreover, the pathway is intimately linked to exosome biogenesis, as ILVs can be secreted as exosomes upon MVB fusion with the plasma membrane, a process that mediates intercellular communication in cancer and other diseases. Understanding the molecular players and regulatory mechanisms of MVB sorting is therefore essential for both basic cell biology and translational research. This article provides a comprehensive overview of GO:0071985, covering its definition, core mechanisms, key genes, disease associations, and state-of-the-art research methods including CRISPR-based models. All facts are drawn from authoritative QuickGO data and verified PubMed literature, ensuring a reliable resource for scientists and AI-driven knowledge retrieval.
multivesicular body sorting pathway At A Glance
| GO ID | GO:0071985 |
|---|---|
| GO term | multivesicular body sorting pathway |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Ubiquitin-dependent sorting of transmembrane proteins into intraluminal vesicles of MVBs for degradation in lysosomes/vacuoles |
| Key machinery | ESCRT complexes (ESCRT-0, -I, -II, -III), VPS4, ALIX, and associated proteins |
| Cellular location | Endosomal membrane, multivesicular body, lysosome/vacuole |
| Related process | Exosome biogenesis, receptor downregulation, endosomal sorting |
| Disease relevance | Cancer, neurodegeneration, developmental disorders |
What Is GO:0071985?
GO:0071985 (multivesicular body sorting pathway) is a biological process defined as a vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs); upon subsequent fusion of MVBs with lysosomes or vacuoles, the cargo proteins are degraded. In simpler terms, it is the cellular sorting system that decides which membrane proteins get sent into the interior of endosomes for destruction, using ubiquitin as a molecular tag and the ESCRT machinery as the sorting apparatus.
Why Is multivesicular body sorting pathway Important in Cell Biology?
The multivesicular body sorting pathway is a central node in cellular protein quality control and signal transduction. By directing ubiquitylated transmembrane proteins into ILVs, it ensures the timely downregulation of receptors and transporters, preventing aberrant signaling that can drive cancer and other diseases. The pathway also intersects with exosome biogenesis, a process that has emerged as a key mechanism of intercellular communication in cancer, immune responses, and neurodegeneration. Furthermore, mutations in ESCRT components are linked to inherited disorders such as spastic paraplegia and frontotemporal dementia, underscoring its physiological importance. For researchers, understanding GO:0071985 provides insights into fundamental cell biology and offers therapeutic targets for a range of pathologies.
• Controls downregulation of growth factor receptors, preventing sustained proliferative signaling in cancer.
• Essential for neuronal survival; ESCRT dysfunction is linked to neurodegeneration.
• Drives exosome biogenesis, which mediates intercellular communication in cancer and immune responses.
• Regulates nutrient sensing and membrane protein homeostasis.
• Involved in viral budding and pathogen egress, as many viruses hijack ESCRT components.
• Provides targets for cancer therapy, as ESCRT proteins are often dysregulated in tumors.
• Plays a role in developmental processes such as cell polarity and differentiation.
• Serves as a model for studying ubiquitin-dependent sorting and membrane deformation.
• Implicated in immune regulation through MHC class II sorting and antigen presentation.
• Offers biomarkers for cancer diagnosis via exosomal cargo.
What Happens During multivesicular body sorting pathway?
Cargo Recognition and Ubiquitination
In simple terms: Proteins destined for degradation get tagged with a molecular label called ubiquitin.
The pathway begins with the ubiquitination of transmembrane cargo proteins by E3 ubiquitin ligases. This post-translational modification serves as a sorting signal that is recognized by ESCRT-0, which contains ubiquitin-binding domains. ESCRT-0, composed of HRS (HGS) and STAM1/2, clusters ubiquitylated cargo on the endosomal membrane and recruits downstream ESCRT components.
ESCRT Complex Assembly and Cargo Concentration
In simple terms: A series of protein complexes assemble on the endosome to gather the tagged proteins.
Following cargo recognition, ESCRT-I and ESCRT-II are sequentially recruited. ESCRT-I (TSG101, VPS28, VPS37, MVB12) and ESCRT-II (VPS22, VPS25, VPS36) further concentrate cargo and initiate membrane invagination. These complexes interact with each other and with ESCRT-0 to form a sorting platform that ensures efficient cargo packaging.
Intraluminal Vesicle Formation and Scission
In simple terms: The membrane buds inward to form small vesicles inside the endosome, pinching off with the help of ESCRT-III.
ESCRT-III, composed of CHMP proteins (e.g., CHMP2A, CHMP4B), assembles into filaments that drive membrane deformation and scission, forming intraluminal vesicles (ILVs). The AAA-ATPase VPS4 catalyzes the disassembly and recycling of ESCRT-III, a step essential for completing the sorting process. The resulting multivesicular body contains multiple ILVs enriched in sorted cargo.
MVB Fusion and Cargo Degradation
In simple terms: The multivesicular body fuses with the lysosome, delivering the internal vesicles for destruction.
Upon maturation, MVBs fuse with lysosomes (or vacuoles in yeast), leading to the degradation of ILVs and their cargo proteins. This terminal step ensures that the sorted transmembrane proteins are irreversibly removed from the cell, completing the downregulation process. Alternatively, MVBs can fuse with the plasma membrane to release ILVs as exosomes, a pathway with important implications for intercellular communication.
Key Genes Involved in GO:0071985 multivesicular body sorting pathway
The following genes and proteins are central to the multivesicular body sorting pathway, based on their established roles in ESCRT-mediated cargo sorting and MVB biogenesis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VPS4A | AAA-ATPase that disassembles ESCRT-III filaments | Essential for MVB sorting; knockout causes ESCRT-III accumulation |
| VPS4B | Paralog of VPS4A; involved in ESCRT-III recycling | Mutations linked to cancer and developmental disorders |
| TSG101 | ESCRT-I component; binds ubiquitinated cargo | Frequently studied in cancer and viral budding |
| CHMP2A | ESCRT-III subunit; drives membrane scission | Knockout impairs ILV formation |
| CHMP4B | ESCRT-III subunit; forms filaments | Mutations associated with cataracts and neurodegeneration |
| STAM1 | ESCRT-0 component; ubiquitin-binding | Regulates receptor downregulation |
| HRS (HGS) | ESCRT-0 component; clusters cargo | Key marker for early endosomes; knockout affects sorting |
| ALIX (PDCD6IP) | Accessory ESCRT protein; binds CHMP4B | Involved in exosome biogenesis and viral budding |
| VPS28 | ESCRT-I component | Required for ESCRT-I stability |
| VPS37 | ESCRT-I component | Modulates cargo recognition |
| MVB12 | ESCRT-I accessory | Regulates ESCRT-I function |
| VPS22 | ESCRT-II component | Involved in cargo sorting |
| VPS25 | ESCRT-II component | Mutations linked to developmental defects |
| VPS36 | ESCRT-II component; binds ubiquitin | Essential for MVB sorting |
| GPR143 | G-protein coupled receptor; controls ESCRT-dependent exosome biogenesis | Promotes cancer metastasis |
| RAB7 | Late endosome marker; regulates MVB fusion | Key regulator of MVB-lysosome fusion |
| SNF8 | ESCRT-II component | Involved in endosomal sorting |
| VTA1 | VPS4 cofactor | Regulates ESCRT-III disassembly |
How Is multivesicular body sorting pathway Regulated?
The multivesicular body sorting pathway is regulated at multiple levels. Ubiquitination of cargo is reversible, and deubiquitinating enzymes (DUBs) can remove ubiquitin tags, thereby influencing sorting efficiency. ESCRT complex assembly and disassembly are tightly controlled by ATP hydrolysis and post-translational modifications, including phosphorylation. The AAA-ATPase VPS4 and its cofactor VTA1 are critical for recycling ESCRT-III subunits, and their activity is regulated by calcium and other signals. Additionally, the pathway intersects with mTOR signaling, which can modulate endosomal trafficking and MVB fusion. In cancer, dysregulation of ESCRT components often occurs at the transcriptional level, affecting pathway activity.
multivesicular body sorting pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSG101 | Cancer, viral budding | Knockout in HeLa cells; viral budding assay |
| CHMP2B | Frontotemporal dementia | Knock-in of disease mutations in neurons |
| VPS4B | Skeletal dysplasia | Knockout in zebrafish or mouse models |
| GPR143 | Cancer metastasis | Overexpression in melanoma cells; exosome analysis |
| ALIX | Cancer, viral budding | Knockout in HEK293T; exosome quantification |
Cancer
Dysregulation of MVB sorting is frequently observed in cancer. Loss of ESCRT components can lead to impaired downregulation of growth factor receptors such as EGFR, resulting in sustained proliferative signaling. Conversely, exosomes derived from MVBs can carry oncogenic cargo and promote metastasis. GPR143, a regulator of ESCRT-dependent exosome biogenesis, has been shown to promote cancer metastasis. Targeting the MVB sorting pathway is therefore an emerging therapeutic strategy.
Neurodegeneration
Neurons are particularly vulnerable to defects in MVB sorting due to their polarized morphology and reliance on efficient protein degradation. Mutations in ESCRT-III components such as CHMP2B are linked to frontotemporal dementia and amyotrophic lateral sclerosis. Impaired MVB sorting can lead to accumulation of toxic proteins, contributing to neurodegeneration.
Developmental Disorders
Mutations in ESCRT genes cause a range of developmental abnormalities. For example, mutations in VPS4B are associated with skeletal dysplasia and other congenital defects. The pathway is essential for cell polarity and differentiation during embryogenesis.
Infectious Diseases
Many enveloped viruses, including HIV and Ebola, hijack the ESCRT machinery to facilitate budding from host cells. This makes the MVB sorting pathway a potential target for antiviral therapies.
From multivesicular body sorting pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of VPS4A impair MVB sorting? | CRISPR knockout in HeLa or HEK293T cells |
| How do disease mutations in CHMP2B affect ESCRT-III function? | Point mutation knock-in in neuroblastoma cells |
| Can tagged ESCRT components be used to track MVB dynamics? | Knock-in of GFP or HaloTag into endogenous loci |
| Does overexpression of GPR143 enhance exosome secretion? | Overexpression in cancer cell lines |
| What is the role of TSG101 in receptor downregulation? | Knockout and rescue with wild-type or mutant TSG101 |
| How does ALIX regulate exosome biogenesis? | Knockout in HEK293T and exosome proteomics |
How to Study the multivesicular body sorting pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Localization of ESCRT components and cargo | Tracking MVB sorting in live cells |
| Electron microscopy | Ultrastructure of ILVs and MVBs | Visualizing MVB morphology |
| Mass spectrometry | Protein composition of exosomes/MVBs | Identifying cargo and biomarkers |
| CRISPR knockout screening | Genes required for MVB sorting | Discovery of novel regulators |
| Ubiquitination assays | Cargo ubiquitination status | Measuring sorting signals |
| In vitro reconstitution | ESCRT-mediated membrane deformation | Mechanistic studies |
| Flow cytometry | Receptor downregulation | Quantifying cargo degradation |
| Exosome isolation and NTA | Exosome size and concentration | Assessing MVB-plasma membrane fusion |
Imaging of MVB Sorting
Fluorescence microscopy, including confocal and super-resolution techniques, allows visualization of ESCRT components and cargo in live cells. Tagged proteins (e.g., GFP-CHMP4B) can be used to track ILV formation and MVB dynamics. Electron microscopy provides ultrastructural details of ILVs.
Proteomic Analysis of Exosomes and MVBs
Mass spectrometry-based proteomics of isolated exosomes or MVBs can identify cargo and ESCRT interactors. This approach has revealed the diverse protein content of exosomes and their role in intercellular communication.
CRISPR Screening for MVB Sorting Regulators
Genome-wide CRISPR knockout screens can identify novel genes required for MVB sorting and exosome biogenesis. Such screens have uncovered regulators like GPR143 and can be combined with FACS-based readouts of cargo degradation.
Biochemical Assays for ESCRT Function
In vitro reconstitution assays using purified ESCRT complexes and liposomes can dissect the molecular mechanisms of membrane deformation and scission. Ubiquitination assays and pull-downs can measure cargo sorting efficiency.
How CRISPR Can Be Used to Study GO:0071985 multivesicular body sorting pathway
Knockout
CRISPR knockout of ESCRT genes such as VPS4A, TSG101, or CHMP2A is widely used to study loss-of-function phenotypes in MVB sorting. Knockout cells often exhibit impaired receptor degradation, accumulation of ubiquitinated cargo, and defects in exosome secretion. These models are valuable for dissecting the specific roles of individual ESCRT components.
Point Mutation
Point mutations identified in human diseases (e.g., CHMP2B mutations in frontotemporal dementia) can be introduced into cell lines using CRISPR-based prime editing or homology-directed repair. Such models help determine whether specific mutations are causal for MVB sorting defects and disease phenotypes.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags into endogenous ESCRT genes allows real-time tracking of protein localization and dynamics. Tagged knock-in models are particularly useful for imaging studies of MVB sorting and exosome biogenesis.
Overexpression
Overexpression of wild-type or mutant ESCRT components, or of cargo proteins, can be achieved via lentiviral transduction or CRISPR activation. Overexpression studies have revealed that GPR143 promotes ESCRT-dependent exosome biogenesis and cancer metastasis. Such models are useful for gain-of-function analyses.
How EDITGENE Supports multivesicular body sorting pathway Research
Researchers studying multivesicular body sorting pathway-related genes often need to determine whether a candidate gene is causally involved in cargo sorting, exosome biogenesis, or disease progression. Generating precise genetic models is essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for multivesicular body sorting pathway research.
Frequently Asked Questions About multivesicular body sorting pathway
What is the multivesicular body sorting pathway?
The multivesicular body sorting pathway (GO:0071985) is a vesicle-mediated transport process in which transmembrane proteins are ubiquitylated and sorted into intraluminal vesicles of multivesicular bodies for degradation in lysosomes or vacuoles.
What genes are involved in multivesicular body sorting?
Key genes include VPS4A, VPS4B, TSG101, CHMP2A, CHMP4B, STAM1, HRS, ALIX, and other ESCRT components.
What is the role of ESCRT in MVB sorting?
The ESCRT machinery (ESCRT-0, -I, -II, -III, and VPS4) sequentially recognizes ubiquitylated cargo, concentrates it, and drives the formation of intraluminal vesicles.
How is the multivesicular body sorting pathway linked to cancer?
Dysregulation of MVB sorting can lead to impaired downregulation of growth factor receptors, sustained proliferative signaling, and increased exosome-mediated metastasis.
What diseases are associated with defects in MVB sorting?
Defects are linked to cancer, neurodegeneration (e.g., frontotemporal dementia), developmental disorders, and infectious diseases.
What is the difference between MVB sorting and exosome biogenesis?
MVB sorting is the process of packaging cargo into intraluminal vesicles; exosome biogenesis occurs when MVBs fuse with the plasma membrane and release these vesicles as exosomes.
How can I study the multivesicular body sorting pathway in the lab?
Common methods include fluorescence microscopy, electron microscopy, proteomics, CRISPR knockout screens, and biochemical assays for ESCRT function.
What are the key ESCRT proteins?
Key ESCRT proteins include HRS, STAM1 (ESCRT-0), TSG101, VPS28 (ESCRT-I), VPS22, VPS25, VPS36 (ESCRT-II), CHMP2A, CHMP4B (ESCRT-III), and VPS4.
Can CRISPR be used to study MVB sorting?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in MVB sorting.
What is the clinical relevance of MVB sorting?
It is relevant for cancer therapy, neurodegenerative disease, and antiviral strategies, as many pathogens hijack the pathway.
Conclusion
The multivesicular body sorting pathway (GO:0071985) is a cornerstone of cellular protein homeostasis and signal transduction. Its core machinery, the ESCRT complexes, orchestrates the ubiquitin-dependent sorting of transmembrane proteins into intraluminal vesicles, leading to their degradation in lysosomes. This pathway is essential for receptor downregulation, exosome biogenesis, and neuronal survival, and its dysfunction is implicated in cancer, neurodegeneration, and developmental disorders. Advances in CRISPR-based models and high-throughput screening are accelerating our understanding of MVB sorting and opening new avenues for therapeutic intervention. Researchers can leverage EDITGENE's services to generate precise genetic models and uncover novel insights into this fundamental process.
References
- 1. Liu J et al.. 2021. The biology, function, and applications of exosomes in cancer.. Acta Pharm Sin B 11(9):2783-2797 PMID: 34589397
- 2. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 3. Scott CC et al.. 2014. Endosome maturation, transport and functions.. Semin Cell Dev Biol 31:2-10 PMID: 24709024
- 4. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 5. Henne WM et al.. 2011. The ESCRT pathway.. Dev Cell 21(1):77-91 PMID: 21763610
- 6. Hanson PI et al.. 2012. Multivesicular body morphogenesis.. Annu Rev Cell Dev Biol 28:337-62 PMID: 22831642
- 7. Katzmann DJ et al.. 2002. Receptor downregulation and multivesicular-body sorting.. Nat Rev Mol Cell Biol 3(12):893-905 PMID: 12461556
- 8. Han QF et al.. 2022. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.. Mol Cancer 21(1):207 PMID: 36320056
